Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin

Cathy Davies, Daniel Martins, Ottavia Dipasquale, Robert A. McCutcheon, Andrea De Micheli, Valentina Ramella-Cravaro, Umberto Provenzani, Grazia Rutigliano, Marco Cappucciati, Dominic Oliver, Steve Williams, Fernando Zelaya, Paul Allen, Silvia Murguia, David Taylor, Sukhi Shergill, Paul Morrison, Philip McGuire, Yannis Paloyelis, Paolo Fusar-Poli
doi: https://doi.org/10.1101/2023.03.17.23286528

Article Information

doi 
https://doi.org/10.1101/2023.03.17.23286528
History 
  • March 21, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Cathy Davies*,1,2,3,#,
  2. Daniel Martins*,3,4,
  3. Ottavia Dipasquale3,
  4. Robert A. McCutcheon2,5,
  5. Andrea De Micheli1,4,
  6. Valentina Ramella-Cravaro1,
  7. Umberto Provenzani1,6,
  8. Grazia Rutigliano1,
  9. Marco Cappucciati1,
  10. Dominic Oliver1,5,
  11. Steve Williams3,
  12. Fernando Zelaya3,
  13. Paul Allen2,7,8,
  14. Silvia Murguia9,
  15. David Taylor10,
  16. Sukhi Shergill2,
  17. Paul Morrison2,
  18. Philip McGuire5,11,12,
  19. Yannis Paloyelis†,3 and
  20. Paolo Fusar-Poli†,1,4,6,13
  1. 1Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
  2. 2Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
  3. 3Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
  4. 4National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, London, UK
  5. 5Department of Psychiatry, University of Oxford, Oxford, UK
  6. 6Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
  7. 7Department of Psychology, University of Roehampton, London, UK
  8. 8Icahn School of Medicine, Mount Sinai Hospital, New York, NY, USA
  9. 9Tower Hamlets Early Detection Service, East London NHS Foundation Trust, London, UK
  10. 10Institute of Pharmaceutical Science, King’s College London, London, UK
  11. 11NIHR Oxford Health Biomedical Research Centre, Oxford, UK
  12. 12Oxford Health NHS Foundation Trust, Oxford, UK
  13. 13Outreach And Support in South London (OASIS) Service, South London and Maudsley NHS Foundation Trust, London, UK
  1. ↵#Corresponding author:
    Dr Cathy Davies, Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, DeCrespigny Park, London, UK, SE5 8AF. Email: cathy.davies{at}kcl.ac.uk

  1. ↵* These authors contributed equally to this work.

Back to top
Posted March 21, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin
Cathy Davies, Daniel Martins, Ottavia Dipasquale, Robert A. McCutcheon, Andrea De Micheli, Valentina Ramella-Cravaro, Umberto Provenzani, Grazia Rutigliano, Marco Cappucciati, Dominic Oliver, Steve Williams, Fernando Zelaya, Paul Allen, Silvia Murguia, David Taylor, Sukhi Shergill, Paul Morrison, Philip McGuire, Yannis Paloyelis, Paolo Fusar-Poli
medRxiv 2023.03.17.23286528; doi: https://doi.org/10.1101/2023.03.17.23286528
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area